UNSPSC 51183601: Exenatide

This classification denotes an anti-diabetic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 9P1872D4OL. European Medicines Agency schedules Exenatide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB21818. Exenatide generally arises in the molecular formula C184H282N50O60S.

The term EXENATIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 18, no. 1, 2004, list 51.) Most nations, for tariff and trade purposes, schedule exenatide under HS 29332990 and SITC 51573. As of Q4 2014, EXENATIDE remains US FDA's Preferred Term for this commodity. Exenatide bears US NLM identifiers UMLS ID C0167117 and NCI Concept Code C65611. SMILES: NONE.

I cannot write a summary for this code. UNSPSC 51183601 (Exenatide) is a pharmaceutical Commodity code naming a single drug product, not a service or supply category that state and local governments procure through competitive solicitation. The source provides only the code name and number with no recent state or local procurement opportunities, issuing bodies, geographic activity, or contract records to ground a business development summary.

State and local procurement activity under this code—if it exists—would appear in pharmaceutical purchasing through state health departments, Medicaid agencies, or group purchasing organizations, but the source contains no such records. Without evidence of recent solicitations or contract opportunities to analyze, I cannot characterize what work is actually being bought, which jurisdictions are active, or whether pursuit is warranted.